澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ALTERITY THERAPEUTICS LTD

0.008

+0.00114.29%

成交量：282.74萬

成交額：2.01萬

市值：8,700.33萬

市盈率：-4.84

高：0.008

開：0.008

低：0.007

收：0.007

52周最高：0.017

52周最低：0.006

股本：108.75億

流通股本：74.75億

量比：2.71

換手率：0.04%

股息：- -

股息率：- -

每股收益(TTM):-0.002

每股收益(LYR):-0.002

淨資產收益率：-47.02%

總資產收益率：-32.54%

市淨率：1.60

市盈率(LYR):-4.21

資料載入中...

總覽公司新聞資訊公告

抄底良機？深度解析「真實收益」 DeFi 代幣

Alterity Therapeutics在2025年國際帕金森病和運動障礙大會上公布ATH434二期試驗積極數據

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ATH.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ATH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATH.AU\",,,,,undefined,":{"symbol":"ATH.AU","market":"AU","secType":"STK","nameCN":"ALTERITY THERAPEUTICS LTD","latestPrice":0.008,"timestamp":1774588320000,"preClose":0.007,"halted":0,"volume":2827419,"delay":0,"changeRate":0.14285714285714285,"nameEN":"ALTERITY THERAPEUTICS LTD","floatShares":7474903343,"shares":10875416329,"eps":-0.001652,"marketStatus":"休市中","change":0.001,"latestTime":"03-27 16:12:00 AEDT","open":0.008,"high":0.008,"low":0.007,"amount":20055,"amplitude":0.142857,"askPrice":0.008,"askSize":8188020,"bidPrice":0.007,"bidSize":20486933,"shortable":3,"etf":0,"ttmEps":-0.001652,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1774825200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.007,"openAndCloseTimeList":[[1774566000000,1774587600000]],"volumeRatio":2.7101949383323123,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ATH.AU","preClose":0.007,"auctionPrice":0.008,"auctionVolume":969,"auction":3,"marketStatus":"盘后竞价","timestamp":1774587642289}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATH.AU\",,,,,undefined,":{"symbol":"ATH.AU","floatShares":7474903343,"roa":"-32.54%","roe":"-47.02%","lyrEps":-0.001899,"volumeRatio":2.7101949383323123,"shares":10875416329,"dividePrice":0,"high":0.008,"amplitude":0.142857,"preClose":0.007,"low":0.007,"week52Low":0.006,"pbRate":"1.60","psRate":"13.11","week52High":0.017,"institutionHeld":0,"latestPrice":0.008,"committee":0.428908,"eps":-0.001652,"divideRate":0,"volume":2827419,"delay":0,"ttmEps":-0.001652,"open":0.008,"prevYearClose":0.008,"prevWeekClose":0.007,"prevMonthClose":0.008,"prevQuarterClose":0.008,"fiveDayClose":0.007,"twentyDayClose":0.008,"sixtyDayClose":0.008},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATH.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATH.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATH.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588603592","title":"抄底良機？深度解析「真實收益」 DeFi 代幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2588603592","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588603592?lang=zh_tw&edition=fundamental","pubTime":"2025-12-02 16:49","pubTimestamp":1764665349,"startTime":"0","endTime":"0","summary":" 市场确实提供了更好的入场点，但“真实收益”的叙事需要仔细甄别。 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2225555","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ATH.AU","BK7101","FDV.AU","BK7002","FDV","TVL.AU","ATH","BK7062","BK4162","ENA.AU"],"gpt_icon":0},{"id":"1152353174","title":"Alterity Therapeutics在2025年國際帕金森病和運動障礙大會上公布ATH434二期試驗積極數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1152353174","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152353174?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 19:42","pubTimestamp":1760010134,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics在2025年国际帕金森病和运动障碍大会期间发布了其ATH434药物二期临床试验的积极研究数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ATH.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}